1832 Asset Management L.P. Seagen Inc. Transaction History

1832 Asset Management L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $3.08 Million - $5.08 Million	28,300 New	28,300 $5.01 Million
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $44.3 Million - $58.4 Million	-370,200 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$142.57 - $190.86 $52.8 Million - $70.7 Million	370,200 New	370,200 $58 Million
Q1 2021 May 17, 2021	SELL	$137.51 - $190.8 $133 Million - $184 Million	-964,500 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $159 Million - $204 Million	964,500 New	964,500 $176 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on 1832 Asset Management L.P. with notifications on news.